Parkway Life Real Estate Investment Trust (SGX:C2PU)

Market Cap	2.64B -2.4%
Revenue (ttm)	155.07M +2.6%
Net Income	165.20M +97.2%
EPS	0.25 +92.6%
Shares Out	652.69M
PE Ratio	16.00
Forward PE	22.31
Dividend	0.15 (3.78%)
Ex-Dividend Date	Aug 12, 2026

Volume	858,100
Open	4.040
Previous Close	4.040
Day's Range	4.040 - 4.080
52-Week Range	3.910 - 4.310
Beta	0.34
Analysts	Strong Buy
Price Target	4.71 (+16.3%)
Earnings Date	Nov 3, 2026

About SGX:C2PU

Parkway Life Real Estate Investment Trust is one of Asia’s largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). Parkway Life Real Estate Investment Trust ...

• Industry: REIT - Healthcare Facilities
• Sector: Real Estate
• Founded: 2007
• Country: Singapore
• Stock Exchange: Singapore Exchange
• Ticker Symbol: C2PU

Financial Performance

In 2025, SGX:C2PU's revenue was 156.29 million, an increase of 7.59% compared to the previous year's 145.27 million. Earnings were 152.79 million, an increase of 60.76%.

Analyst Summary

According to 7 analysts, the average rating for C2PU stock is "Strong Buy." The 12-month stock price target is $4.71, which is an increase of 16.30% from the latest price.

Price Target

$4.71

(16.30% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 22, 2026

Data Sources Report a data error